EGFR TKI–Based Combinations May Revolutionize Frontline EGFR+ NSCLC Management
Balazs Halmos, MD, discusses the FLAURA2 and MARIPOSA trials of EGFR TKIs plus chemotherapy in EGFR-mutated non–small cell lung cancer.
Source: onclive.com
Stay updated with breaking news from Winter Lung. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Balazs Halmos, MD, discusses the FLAURA2 and MARIPOSA trials of EGFR TKIs plus chemotherapy in EGFR-mutated non–small cell lung cancer.
Whether this year’s festival pans out that way will only transpire later this month. But, one thing is for sure, there is something for practically everyone in the offing right across the country.